Status:
UNKNOWN
Functional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Oropharynx Cancer
Pain
Eligibility:
All Genders
18+ years
Brief Summary
To investigate the treatment related effects of transoral robotic surgery (TORS) or oncological treatment of oropharyngeal squamous cell carcinoma with a 1-year follow up.
Detailed Description
Patients are enrolled prospectively at the department of Otorhinolaryngology, Head and Neck Surgery \& Audiology at Copenhagen University Hospital, Rigshospitalet. All eligible patients with histolog...
Eligibility Criteria
Inclusion
- TORS group:
- WHO performance status 0-2
- Squamous cell carcinoma of the oropharynx
- TNM: T1-2, N0-1 (without of evidence of extra capsular extent), M0.
- No previous head and neck cancer
- Absence of factors that inhibit the patient from participate in all or parts of the study e.g. geographical, mental, cognitive or other.
- Signed written consent.
- Cancer eligible for surgery in the absence of significant trismus.
- Oncological group:
- WHO performance status 0-2
- Squamous cell carcinoma of the oropharynx
- Qualified for curative intended oncological treatment
- Signed written consent
Exclusion
- TORS group:
- Serious co-morbidity
- Distant metastasis
- Previous radiotherapy to the head and neck region.
- Concurrent treatment eller investigations for another cancer, except carcinoma in situ.
- Oncological group:
- Previous radiotherapy to the head and neck region.
- Concurrent treatment eller investigations for another cancer, except carcinoma in situ.
- Presence of factors that inhibit the patient from participate in all or parts of the study e.g. geographical, mental, cognitive or other.
- Presence of facors that inhibit the patient from completing the treatment.
- Previous head and neck cancer
- Distant metastasis
Key Trial Info
Start Date :
April 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03418909
Start Date
April 1 2017
End Date
June 30 2024
Last Update
March 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100